Chaire Innovation BOPA

What Chaire Innovation BOPA does

Chaire Innovation BOPA (Bloc Opératoire Augmenté) is a French academic research chair founded in January 2020 and hosted at Hôpital Paul Brousse in Villejuif, within the Assistance Publique-Hôpitaux de Paris (AP-HP) system. It is jointly founded by three institutional members — AP-HP, Institut Mines-Télécom, and Université Paris-Saclay — and is dedicated to proof-of-concept innovation in hepatobiliary-pancreatic (HPB) surgery. Its operations are anchored in a unique 158 m² mock operating room co-located with the real operating theaters of the Centre Hépato-Biliaire (CHB), France's first liver transplant center, which performs over 200 transplantations and 150 hepatectomies annually.

The chair's product portfolio spans patient-facing visualization tools (LiverSight and PancreasSight 3D applications), AI-driven decision support and workflow tools (Colette chatbot for transplant patients, Anyo algorithm for surgeon scheduling optimization), and industry-facing preclinical and clinical testing platforms (the BopTech platform with a Philips Azurion 7 AI-enhanced hybrid operating room, and InMachina's 7-14 day ex vivo cancerous human liver perfusion model). Research output totals 46 scientific publications and 48 conference presentations, and one spin-off startup (Uncovr, 2025) has been created to commercialize AI-based automatic surgical procedure coding.

BOPA's revenue model is grant- and sponsorship-driven rather than commercial. Corporate mécène companies contributed 1.6 million euros over the BOPA 1 phase (2020-2024), supplemented by platform funding from AP-HP, the Paris Saclay Cancer Cluster (PSCC), and Bpifrance for BopTech. Industry partners access testing infrastructure through BopTech, while IP licensing, academic research fellowships (23,000 EUR each), and startup equity constitute secondary revenue mechanics. A second framework agreement (BOPA 2, 2025-2030) extends operations through 2030 with an expanded scientific scope covering pre-, per-, and post-operative patient pathways.

Name

Chaire Innovation BOPA

Legal name

Assistance Publique-Hôpitaux de Paris

Website

https://chaire-bopa.fr

Company type

Private

Founded year

2020

Operating status

Operating

Headcount range

1–10 employees

Short description

Chaire Innovation BOPA is a French academic research chair founded in 2020 by AP-HP, Institut Mines-Télécom, and Université Paris-Saclay, focused on proof-of-concept innovation for hepatobiliary-pancreatic surgery at Hôpital Paul Brousse, combining AI tools, 3D visualization, and industry-facing preclinical platforms.

Ownership category

akta.pro rank

Product category

Surgical Innovation Research and Digital Health Tools

NAICS

Research and Development in the Physical, Engineering, and Life Sciences (54171), Custom Computer Programming Services (541511)

SIC

Services-Prepackaged Software (7372)

akta.pro primary industry

Clinical CROs (Phase I–IV) (HLAGAAAA)

akta.pro secondary industry

Clinical Research Support (CRC/CTA) (EDAOAJAO)

Keywords

• Surgical innovation research
• Digital health platform
• Hepatobiliary surgery
• Medical device validation
• Augmented operating room

Headquarters

HQ city

Villejuif

HQ country

France

HQ region

Europe

Offices2 records

Markets served

GTM type

B2B

Offering type

Software

Cost components

Personnel, Technology or R&D, Infrastructure, Operations

Revenue model

1. Corporate Sponsorship and Research Funding:
2. Intellectual Property Licensing:
3. Innovation Testing and Validation Services:
4. Startup Equity/Technology Transfer:

Go-to-market motion3 records

Distribution channels4 records

Marketing channels5 records

Core offering

Chaire Innovation BOPA is an academic research chair that conducts proof-of-concept innovation for hepatobiliary-pancreatic surgery. It develops and validates digital health tools (LiverSight, Colette, Anyo, PancreasSight), operates the BopTech technology platform with a hybrid operating room and InMachina ex vivo liver perfusion system, and transfers innovations to MedTech/Biotech industry partners and spin-off startups. All innovations are prototyped in a 158 m² fake operating room before validation at the Centre Hépato-Biliaire.

Product overview

Chaire Innovation BOPA is a research innovation chair focused on the 'Augmented Operating Room' (Bloc Opératoire Augmenté), dedicated to proof-of-concept research for hepatobiliary and pancreatic surgery. The portfolio comprises patient communication tools (LiverSight and PancreasSight for 3D surgical visualization), AI-powered solutions (Colette chatbot for transplant patient support, Anyo for surgeon scheduling optimization), preclinical platforms (InMachina ex vivo liver model, Hybrid Room with Philips Azurion 7), and a technology platform (BopTech). The ecosystem has produced one spin-off startup (Uncovr for automatic surgical coding). All innovations are tested in a 158 m2 fake operating room before validation at the Hepatobiliary Center, France's first liver transplant center.

Differentiator

Problem solved

Functional benefit

Brands

• BopTech: A technological and scientific platform funded by AP-HP, Paris Saclay Cancer Cluster (PSCC), and Bpifrance, located within the Centre Hépato-Biliaire operating rooms, dedicated to innovation in image-guided surgery, endoscopy, and hepatobiliary and pancreatic oncology.
• Week-end de l'Innovation Chirurgicale (WIC)
• InMachina
• BOpEx
• LiverSight
• Colette
• Anyo

Products and services

• LiverSight A 3D immersive visualization application that helps physicians explain liver tumors and surgical procedures to patients. It enables simulation, comparison, and explanation of therapeutic options in real-time, generating personalized PDFs with key diagrams and information for shared decision-making.
• Colette A 24/7 chatbot that answers frequent questions from liver transplant patients. Available to support patients post-operation regarding medications, diet, medical follow-up, lifestyle, warning signs, and physical activity.
• Anyo An AI algorithm that optimizes the scheduling and distribution of surgeon on-call duties, reducing fatigue and improving team atmosphere, ultimately making surgical procedures safer.
• PancreasSight A patient-physician communication tool similar to LiverSight, designed to better inform and reassure patients before pancreatic surgery operations.
• BopTech Platform A technological and scientific platform funded by AP-HP, Paris Saclay Cancer Cluster (PSCC), and BPI France, located within the operating room of the Hepatobiliary Center (CHB). Connects MedTech, Biotech, and academic research actors to accelerate development of minimally invasive solutions for hepatobiliary and pancreatic cancer patients.
• InMachina A preclinical model that maintains cancerous human livers (CHC, CCK, metastases) in quasi-physiological conditions for 7 to 14 days, enabling biotech, medtech, and health industry players to test innovations in an ultra-realistic ex vivo environment before clinical trials.
• Hybrid Room (Salle Hybride) A hybrid operating room at CHB equipped with Philips Azurion 7 system enhanced by artificial intelligence, enabling image-guided surgery, endoscopy, ultrasound, and interventional radiology for testing and validating MedTech innovations in real conditions.
• Uncovr A startup created in 2025 with the ambition of developing methods to automatically code surgical procedures using artificial intelligence. Represents the first spin-off from the chair's innovation activities.

Quantifiable outcome

• 46 scientific articles published and 48 conference presentations generated through research activities
• +2 more outcomes

Named customers2 records

Segments4 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability4 records

Feature6 records

Partnerships

Five partnerships are on record, tiered core and flagship.

• UncovrcoreStrategic or Co-development Partner · 1 January 2025Startup created in 2025 from BOPA research with the ambition to develop automatic surgical procedure coding methods. Represents the first spin-off from the chair's innovation activities.
• InMachinacoreStrategic or Co-development Partner · 1 January 2025Project supported by PSCC that maintains cancerous human livers in quasi-physiological conditions for 7-14 days, opening new pathways in translational medicine for preclinical testing by biotech, medtech, and health industry players.
• AP-HP (Assistance Publique-Hôpitaux de Paris)flagshipStrategic or Co-development Partner · 1 January 2020One of three founding members of the Chaire Innovation BOPA. AP-HP provides the clinical environment at Hôpital Paul-Brousse, including the Centre Hépato-Biliaire, access to operating rooms, and institutional hosting. The chair was officially launched with its first steering committee in January 2020. A second framework agreement extends the partnership through 2030.
• Institut Mines-TélécomflagshipStrategic or Co-development Partner · 1 January 2020One of three founding members of the Chaire Innovation BOPA. IMT provides engineering expertise and contributes engineers who work alongside healthcare professionals and academic researchers within the chair's facilities.
• Université Paris-SaclayflagshipStrategic or Co-development Partner · 1 January 2020One of three founding members of the Chaire Innovation BOPA. Contributes academic research expertise through researchers from the university and CNAM who collaborate within the chair's multi-disciplinary innovation environment.

Scale indicators6 records

Recent moves10 records

Expansion highlights6 records

Emerging players

• FundamentalVR: UK-based HapticVR surgical simulation and training platform. Comparable as an emerging digital surgery player with academic-clinical validation roots and 3D surgical visualization, though focused on training rather than BOPA's per-operative innovation.
• Surgical Science: Swedish company providing virtual reality simulators for medical training, including minimally invasive surgery. Comparable to BOPA's digital surgery portfolio but with a focus on simulation training products rather than clinical innovation testing.
• Osso VR: Surgical VR training and assessment platform used by medical device companies and academic centers. Comparable to BOPA in combining digital visualization with academic clinical environments, but commercially focused on training rather than live surgical innovation.
• Visible Patient: French company providing 3D anatomical modeling and surgical planning from medical imaging. Comparable to BOPA's LiverSight 3D visualization, though commercially developed for broader surgical planning rather than hepatobiliary specialization.

Direct peers

• IHU Strasbourg: Institut Hospitalo-Universitaire de Strasbourg is a hospital-university institute focused on minimally invasive image-guided surgery, combining engineering and clinical research. Highly comparable to BOPA as a French hybrid academic-clinical innovation hub for image-guided surgery.
• IRCAD: Institut de Recherche contre les Cancers de l'Appareil Digestif is a Strasbourg-based surgical research and training institute focused on minimally invasive surgery and innovation in digestive cancers. Direct peer to BOPA in its dual mission of surgical innovation + research/training + industry partnerships in visceral surgery.

Broad incumbents

• Brainlab: A global incumbent in image-guided surgery, surgical planning, and intra-operative visualization. Comparable to BOPA's Hybrid Room and LiverSight capabilities at commercial scale, but operating across all surgical specialties rather than hepatobiliary focus.
• Philips (Image-Guided Therapy): Global health technology incumbent and direct partner to BOPA via the Philips Azurion 7 system in the Hybrid Room. Comparable as a broad incumbent providing the underlying image-guided therapy platform that BOPA innovations are built upon.
• Inria: France's national digital science research institute, partner to BOPA. Comparable as a French public R&D ecosystem providing engineering and computational talent to clinical innovation, but operating at a much broader national scale across multiple domains.

Others

• BOpEx (AP-HP): The experimental tier-lieu (third place) at the former Broussais hospital site, distinct from but institutionally related to Chaire BOPA. Comparable as the AP-HP innovation gateway that routes opportunities to BOPA, functioning as a sister ecosystem entity.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat6 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/chaire-innovation-bopa

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Subsidiaries1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Chaire Innovation BOPA